methylprednisolone has been researched along with sincalide in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Boros, I; Duda, E; Iványi, B; Kaszaki, J; Lonovics, J; Rakonczay, Z; Takács, T | 1 |
1 review(s) available for methylprednisolone and sincalide
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
1 other study(ies) available for methylprednisolone and sincalide
| Article | Year |
|---|---|
The anti-inflammatory effect of methylprednisolone occurs down-stream of nuclear factor-kappaB DNA binding in acute pancreatitis.
Topics: Acute Disease; Amylases; Animals; Anti-Inflammatory Agents; Body Weight; Chaperonin 60; DNA; Dose-Response Relationship, Drug; Enzyme Activation; HSP70 Heat-Shock Proteins; I-kappa B Proteins; Interleukin-6; Lipid Peroxides; Male; Methylprednisolone; NF-kappa B; NF-KappaB Inhibitor alpha; Oligopeptides; Organ Size; Oxidation-Reduction; Pancreas; Pancreatitis; Peroxidase; Protein Binding; Proteins; Rats; Rats, Wistar; Sincalide; Sulfhydryl Compounds; Time Factors; Tumor Necrosis Factor-alpha | 2003 |